Discontinued — last reported Q3 '25
Share Buybacks
Idexx Laboratories Share Buybacks increased by 47.6% to $351.04M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.4%, from $400.89M to $351.04M. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows an upward trend with a 13.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Large repurchases signal that management believes the stock is undervalued or that they have excess cash with no better internal investment opportunities.
Detailed definition
The cash spent by a company to buy back its own shares from the open market. This reduces the total number of shares out...
Peer comparison
Highly profitable tech giants often prioritize repurchases over dividends due to tax efficiencies and the impact on EPS.
share_repurchasesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $188.53M | $181.23M | $244.76M | $266.30M | $306.77M | $172.63M | $74.02M | $0.00 | $0.00 | $35.07M | $36.85M | $154.76M | $215.52M | $220.76M | $245.99M | $400.89M | $338.11M | $240.20M | $237.77M | $351.04M |
| QoQ Change | — | -3.9% | +35.0% | +8.8% | +15.2% | -43.7% | -57.1% | -100.0% | — | — | +5.1% | +320.0% | +39.3% | +2.4% | +11.4% | +63.0% | -15.7% | -29.0% | -1.0% | +47.6% |
| YoY Change | — | — | — | — | +62.7% | -4.7% | -69.8% | -100.0% | -100.0% | -79.7% | -50.2% | — | — | +529.5% | +567.5% | +159.0% | +56.9% | +8.8% | -3.3% | -12.4% |
Share Buybacks at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's share buybacks?
- Idexx Laboratories (IDXX) reported share buybacks of $351.04M in Q1 2026.
- How has Idexx Laboratories's share buybacks changed year-over-year?
- Idexx Laboratories's share buybacks decreased by 12.4% year-over-year, from $400.89M to $351.04M.
- What is the long-term trend for Idexx Laboratories's share buybacks?
- Over 4 years (2021 to 2025), Idexx Laboratories's share buybacks has grown at a 13.0% compound annual growth rate (CAGR), from $746.78M to $1.22B.
- What does share buybacks mean?
- The money a company spends to buy back its own stock.